Transarterial Therapies for Hepatocellular Carcinoma

被引：5
|
作者：
Makramalla, Abouelmagd [1 ]
Itri, Jason N. [1 ]
Choe, Kyuran Ann [1 ]
Ristagno, Ross L. [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Dept Radiol, UC Hlth, 234 Goodman St,ML 0761, Cincinnati, OH 45267 USA
来源：
SEMINARS IN ROENTGENOLOGY | 2016年 / 51卷 / 02期
关键词：
MR-IMAGING DIAGNOSIS; DRUG-ELUTING BEADS; PROGNOSTIC-FACTORS; CHEMOEMBOLIZATION; RADIOEMBOLIZATION; LIVER; SURVIVAL; CT; REDUCTION; EFFICACY;
D O I：
10.1053/j.ro.2016.02.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：95 / 105
页数：11
相关论文
共 50 条
  • [1] Transarterial Therapies for Hepatocellular Carcinoma
    Lanza, Ezio
    Donadon, Matteo
    Poretti, Dario
    Pedicini, Vittorio
    Tramarin, Marco
    Roncalli, Massimo
    Rhee, Hyungjin
    Park, Young Nyun
    Torzilli, Guido
    LIVER CANCER, 2017, 6 (01) : 27 - 33
  • [2] Transarterial therapies for hepatocellular carcinoma
    Sangro, Bruno
    D'Avola, Delia
    Inarrairaegui, Mercedes
    Prieto, Jesus
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (07) : 1057 - 1073
  • [3] Locoregional Transarterial Therapies for Hepatocellular Carcinoma: Transarterial Chemoembolization and Radioembolization
    Inarrairaegui, Mercedes
    D'Avola, Delia
    Sangro, Bruno
    VISZERALMEDIZIN, 2013, 29 (02): : 92 - 102
  • [4] Current research status of transarterial therapies for hepatocellular carcinoma
    Zhou, Mao-Ting
    Zhang, Peng
    Mao, Qi
    Wei, Xiao-Qin
    Yang, Lin
    Zhang, Xiao-Ming
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (09)
  • [5] Transarterial therapies for hepatocellular carcinoma (HCC): A long way towards standardization
    Tsochatzis, Emmanuel A.
    Meyer, Tim
    O'Beirne, James
    Burroughs, Andrew K.
    JOURNAL OF HEPATOLOGY, 2013, 58 (01) : 194 - 194
  • [6] Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma
    Hulin, Anne
    Stocco, Jeanick
    Bouattour, Mohamed
    CLINICAL PHARMACOKINETICS, 2019, 58 (08) : 983 - 1014
  • [7] Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
    Perfahl, H.
    Jain, H., V
    Joshi, T.
    Horger, M.
    Malek, N.
    Bitzer, M.
    Reuss, M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma
    Anne Hulin
    Jeanick Stocco
    Mohamed Bouattour
    Clinical Pharmacokinetics, 2019, 58 : 983 - 1014
  • [9] Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
    H. Perfahl
    H. V. Jain
    T. Joshi
    M. Horger
    N. Malek
    M. Bitzer
    M. Reuss
    Scientific Reports, 10
  • [10] Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis
    Patel, Mikin V.
    Davies, Heather
    Williams, Abimbola O.
    Bromilow, Tom
    Baker, Hannah
    Mealing, Stuart
    Holmes, Hayden
    Anderson, Nicholas
    Ahmed, Osman
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1061 - 1071
12345